Cargando…

Regulating Glucagon Secretion: Somatostatin in the Spotlight

Detalles Bibliográficos
Autor principal:	Rutter, Guy A.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628599/ https://www.ncbi.nlm.nih.gov/pubmed/19171745 http://dx.doi.org/10.2337/db08-1534

Ejemplares similares

The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice
por: Ørgaard, Anne, et al.
Publicado: (2017)

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion
por: Vergari, Elisa, et al.
Publicado: (2019)

Cyclic AMP links glucose stimulation to somatostatin secretion in δ-cells
por: Tengholm, Anders
Publicado: (2019)

Glucose Control of Glucagon Secretion: There Is More to It Than K(ATP) Channels
por: Gylfe, Erik
Publicado: (2013)

A Variation on the Theme: SGLT2 Inhibition and Glucagon Secretion in Human Islets
por: Hodson, David J., et al.
Publicado: (2020)

Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
por: Kimura, Tomohiko, et al.
Publicado: (2022)

Spotlight on… Janet K. Jansson
por: Jansson, Janet K.
Publicado: (2016)

Small Mouse Islets Are Deficient in Glucagon-Producing Alpha Cells but Rich in Somatostatin-Secreting Delta Cells
por: Lau, Joey, et al.
Publicado: (2016)

Red‐shifted optogenetics comes to the spotlight
por: Wang, Tianlu, et al.
Publicado: (2022)

Postprandial Insulin Secretion After Gastric Bypass Surgery: The Role of Glucagon-Like Peptide 1
por: Holst, Jens Juul
Publicado: (2011)

Basal hypersecretion of glucagon and insulin from palmitate-exposed human islets depends on FFAR1 but not decreased somatostatin secretion
por: Kristinsson, H., et al.
Publicado: (2017)

Mechanisms of the Regulation and Dysregulation of Glucagon Secretion
por: Onyango, Arnold N.
Publicado: (2020)

Neuronal regulation of glucagon secretion and gluconeogenesis
por: Thorens, Bernard
Publicado: (2022)

Eculizumab and aHUS: Spotlight on Patient-Centered Care
por: Rafat, Cédric, et al.
Publicado: (2020)

Insulin Reciprocally Regulates Glucagon Secretion in Humans
por: Cooperberg, Benjamin A., et al.
Publicado: (2010)

Regulation of glucagon‐like peptide‐1 sensitivity by gut microbiota dysbiosis
por: Yamane, Shunsuke, et al.
Publicado: (2017)

Spotlight commentary: REBUS and the anarchic brain
por: Noorani, Tehseen, et al.
Publicado: (2020)

α-cell electrophysiology and the regulation of glucagon secretion
por: Gao, Rui, et al.
Publicado: (2023)

Novel Insights Into the Regulation of Postprandial Lipemia by Glucagon-Like Peptides: Significance for Diabetes
por: Watts, Gerald F., et al.
Publicado: (2013)

Microtubule reorientation in the blue spotlight: Cutting and CLASPing at dynamic hot spots
por: Benoit, Béatrice, et al.
Publicado: (2019)

N- and C-terminal interactions in KCNH channels: The spotlight on the intrinsic ligand
por: Brelidze, Tinatin I.
Publicado: (2019)

Spotlight on Human Papillomavirus Vaccination Coverage: Is Nigeria Making Any Progress?
por: Okolie, Elvis Anyaehiechukwu, et al.
Publicado: (2023)

Defective Glucagon-Like Peptide 1 Secretion in Prediabetes and Type 2 Diabetes Is Influenced by Weight and Sex. Chicken, Egg, or None of the Above?
por: Vella, Adrian, et al.
Publicado: (2015)

Central nervous system tumors: Spotlight on India
por: Munshi, Anusheel
Publicado: (2016)

Glucagon signaling in the heart: Activation or inhibition?()
por: Pocai, Alessandro
Publicado: (2014)

TGF-β Mediated Immune Evasion in Cancer—Spotlight on Cancer-Associated Fibroblasts
por: Ghahremanifard, Parisa, et al.
Publicado: (2020)

Spotlight on Accessory Proteins: RTK-RAS-MAPK Modulators as New Therapeutic Targets
por: Pudewell, Silke, et al.
Publicado: (2021)

siRNA targeting ANGPTL3 stands in the spotlight for lipid-lowering therapy
por: Hu, Bo, et al.
Publicado: (2023)

Glucose inhibits glucagon secretion by decreasing [Ca(2+)](c) and by reducing the efficacy of Ca(2+) on exocytosis via somatostatin-dependent and independent mechanisms
por: Singh, Bilal, et al.
Publicado: (2022)

Olfactory marker protein regulation of glucagon secretion in hyperglycemia
por: Oh, Ju Hun, et al.
Publicado: (2022)

Glucagon regulates lipolysis and fatty acid oxidation through inositol triphosphate receptor 1 in the liver
por: Hayashi, Yoshitaka
Publicado: (2020)

Glucagon as a Critical Factor in the Pathology of Diabetes
por: Edgerton, Dale S., et al.
Publicado: (2011)

Ketosis-Prone Atypical Diabetes: Glucagon Is There, Too
por: Lefèbvre, Pierre
Publicado: (2013)

Somatostatin Receptor Type 2 Antagonism Improves Glucagon Counterregulation in Biobreeding Diabetic Rats
por: Karimian, Negar, et al.
Publicado: (2013)

IFN-λ: A new spotlight in innate immunity against influenza virus infection
por: Sun, Yeping, et al.
Publicado: (2018)

The SARS-CoV-2 pandemic puts the spotlight on gender inequality in clinical research
por: Søgaard, Mette, et al.
Publicado: (2021)

Role of Fibroblast Growth Factor 21 in Biology of Glucagon
por: Berglund, Eric D., et al.
Publicado: (2013)

The Insulin:Glucagon Ratio and the Choice of Glucose-Lowering Drugs
por: Kalra, Sanjay, et al.
Publicado: (2016)

Is ghrelin a glucagon‐like peptide‐1 secretagogue?
por: Ueno, Hiroaki, et al.
Publicado: (2015)

Clinical Trials, Triumphs, and Tribulations of Glucagon Receptor Antagonists
por: Pearson, Mackenzie J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0581lste24qrs2fiumo7g16j4v